masofaniten
ESSA Pharma Terminates Masofaniten Development After Phase 2 Trial Failure in Prostate Cancer
ESSA Pharma, Masofaniten, Prostate Cancer, Phase 2 Trial, Enzalutamide, Xtandi, Clinical Trial Termination
Actionable Insights Powered by AI
ESSA Pharma, Masofaniten, Prostate Cancer, Phase 2 Trial, Enzalutamide, Xtandi, Clinical Trial Termination